Drug-related Problems and their Predictors among Breast Cancer Patients Receiving Chemotherapy in National Cancer Institute, Malaysia

被引:0
|
作者
Abdulrahman, Egbal [1 ]
Kassab, Yaman Walid [1 ]
Jamaluddln, Nurul Adilla Hayat [1 ]
Iqbal, Muhammad Shahid [2 ]
Khan, Salah-Ud-Din [3 ]
Al-Saikan, Fahad, I [2 ]
Ahmed, M. Azmin [4 ]
机构
[1] Univ Cyberjaya, Dept Hosp & Clin Practice, Fac Pharm, Cyberjaya 63000, Selangor, Malaysia
[2] Prince Sattam bin Abdulaziz Univ, Coll Pharm, Dept Clin Pharm, Al Kharj 11942, Saudi Arabia
[3] Imam Mohammad Ibn Saud Islamic Univ, Coll Med, Dept Biochem, Riyadh, Saudi Arabia
[4] Univ Malaysia, Sch Pharm, Kuala Lumpur, Malaysia
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2021年 / 40卷 / 03期
关键词
adverse drug reactions (ADRs); breast cancer; drug-related problems (DRPs); National Cancer Institute (IKN); risk factors; EVENTS; ERRORS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Breast cancer patients receiving chemotherapy are at high risk of drug-related problems (DRPs), as it is estimated that around 5-10% of hospital admissions are due to DRPs. Breast cancer management is a leading cause of these DRPs in which the drug toxicity is considered as the main cause that makes DRPs very prevalent. Hence, this study aimed to assess DRPs and their predictors among breast cancer patients receiving chemotherapy at the National Cancer Institute (IKN), Malaysia. Breast cancer patients with any stage and type aged >= 18 years and receiving chemotherapy between January and December 2017 were included. DRPs were classified according to a modified form of the Pharmaceutical Care Network Europe (PCNE). Statistical analysis was done by Statistical Package for Social Science (SPSS) software version 24. For categorical data, the Chi-squared test was used to determine the association of patients' characteristics and the occurrence of DRPs. A p < 0.05 was assumed as statistically significant among the obtained results. Overall, 100 patients were included in the study. The majority was Malays 59 (59%) and aged between 25-67 years. A total of 157 DRPs were identified in 78 patients, translating to a prevalence of 78%. Adverse drug reactions (ADRs) were the most common DRPs (47.8%). The most frequent ADR was neutropenia which encountered in 50 patients with prevalence 14.6% of the total ADRs followed by chemotherapy induced nausea and vomiting (CINV) 42 (12.5%). Other DRPs such as drug-drug interactions, drug selection and drug dosing were less common. It was predicted with increasing the number of co-morbidities, DRPs were more likely to occur (OR = 2.279, 95%, CI 1.098-4.730, p = 0.027). DRPs were common in breast cancer patients receiving chemotherapy. The predominant proportion of DRPs was ADRs. Number of co-morbidities was a predictor of the DRPs among the studied cohort of the patients.
引用
收藏
页码:565 / 571
页数:7
相关论文
共 50 条
  • [31] The development of anticipatory nausea in patients receiving adjuvant chemotherapy for breast cancer
    Montgomery, GH
    Bovbjerg, DH
    PHYSIOLOGY & BEHAVIOR, 1997, 61 (05) : 737 - 741
  • [32] Taste Disorders Effect of education in patients with breast cancer receiving chemotherapy
    Asano, Sanae
    Sawatari, Hiroyuki
    Mentani, Hideko
    Shimada, Yuko
    Takahashi, Michie
    Fudano, Kazumi
    Sasaki, Keiko
    Niitani, Mayumi
    Tanabe, Kazuaki
    Kataoka, Tsuyoshi
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2020, 24 (03) : 265 - 271
  • [33] Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy
    Hurria, A
    Brogan, K
    Panageas, KS
    Pearce, C
    Norton, L
    Jakubowski, A
    Zauderer, M
    Howard, J
    Hudis, C
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 92 (02) : 151 - 156
  • [34] Obesity is not associated with increased myelosuppression in patients receiving chemotherapy for breast cancer
    Jenkins, Peter
    Elyan, Sean
    Freeman, Sylvie
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (03) : 544 - 548
  • [35] Modulation of Interhemispheric Functional Coordination in Breast Cancer Patients Receiving Chemotherapy
    Tao, Longxiang
    Wang, Lu
    Chen, Xingui
    Liu, Fujun
    Ruan, Feiyan
    Zhang, Jingjie
    Shen, Li
    Yu, Yongqiang
    FRONTIERS IN PSYCHOLOGY, 2020, 11
  • [36] Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy
    Arti Hurria
    Kelly Brogan
    Katherine S. Panageas
    Carol Pearce
    Larry Norton
    Ann Jakubowski
    Marjorie Zauderer
    Jane Howard
    Clifford Hudis
    Breast Cancer Research and Treatment, 2005, 92 : 151 - 156
  • [37] Fatigue in patients with breast cancer receiving adjuvant chemotherapy: A review of the literature
    de Jong, N
    Courtens, AM
    Abu-Saad, HH
    Schouten, HC
    CANCER NURSING, 2002, 25 (04) : 283 - 297
  • [38] Energy balance in early breast cancer patients receiving adjuvant chemotherapy
    Harvie, MN
    Campbell, IT
    Baildam, A
    Howell, A
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 83 (03) : 201 - 210
  • [39] Chemotherapy-Related Hospitalization Among Community Cancer Center Patients
    Hassett, Michael J.
    Rao, Sowmya R.
    Brozovic, Suzana
    Stahl, James E.
    Schwartz, Joel H.
    Maloney, Betty
    Jacobson, Joseph O.
    ONCOLOGIST, 2011, 16 (03) : 378 - 387
  • [40] Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing
    Roberts, Megan C.
    Weinberger, Morris
    Dusetzina, Stacie B.
    Dinan, Michaela A.
    Reeder-Hayes, Katherine E.
    Troester, Melissa A.
    Carey, Lisa A.
    Wheeler, Stephanie B.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 153 (01) : 191 - 200